‘Ibogaine. Remember the Name’: Trump Admin. Puts $4.9 Million Behind Psychedelic PTSD Research for Veterans
The latest federal investment brings ibogaine—yes, the Schedule I substance—one step closer to U.S. clinical trials, months after Trump signed an executive order to accelerate psychedelic research and directed at least $50 million in existing federal funds toward the effort. The Donald Trump administration is putting more federal money behind a psychedelic substance that has […]